PD-019 ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Autor: Mazzaferro, V., Shaib, W., Rimassa, L., Harris, W., Personeni, N., El-Rayes, B., Tolcher, A., Hall, T., Wang, Y., Schwartz, B., Kazakin, J., Droz Dit Busset, M., Cotsoglou, C., Papadopoulos, K.
Zdroj: In Annals of Oncology June 2016 27 Supplement 2:ii109-ii109
Databáze: ScienceDirect